A New Milestone in Electronic Fetal Monitoring: FDA 510(k) Clearance Granted for Dawes-Redman CTG Analysis™

A New Milestone in Electronic Fetal Monitoring: FDA 510(k) Clearance Granted for Dawes-Redman CTG Analysis™

ADDISON, Ill., March 24, 2025 /PRNewswire/ -- Huntleigh Healthcare is proud to announce that the world-renowned Dawes-Redman CTG Analysis™ has been approved for use in the U.S. by the Food and Drug Administration (FDA). This landmark achievement aims to assist…

FDA grants 510(k) clearance for Huntleigh’s CTG Analysis

The FDA has granted 510(k) approval for UK-based Huntleigh Healthcare’s Dawes-Redman CTG Analysis for foetal monitoring applications.The post FDA grants 510(k) clearance for Huntleigh’s CTG Analysis appeared first on Medical Device Network.